ATG5 and neoplasm: ATG5 silencing impaired OXPHOS and reduced mitochondrial function, but similar glycolysis rates and glycolytic capacity, reflected by the extracellular acidification rate, were observed between primary Atg5 KO and Atg5 WT tumor cells [38].